Ireland
--:--IST
Recruiting Not applicable

The Effects of Different Vibration Exercises on COPD Patients

NCT06413524 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2024-08-08
Last updated
2025-01-16

Condition(s) studied

COPDCOPD Chronic Obstructive Pulmonary DiseaseVibration Therapy

Investigational drug(s) / intervention(s)

Whole-body Vibration TherapyLocal Vibration Therapy

Whole-body Vibration Therapy: Each session includes six series, each lasting 2 minutes, with a frequency of 35 Hz and an amplitude of 2 mm, with a 60-second rest interval between series. For the starting position, the patient stands relaxed on the platform, holding the WBV platform handles.

Local Vibration Therapy: Each session includes six series, each lasting 2 minutes, with a frequency of 35 Hz and an amplitude of 2 mm, with a 60-second rest interval between series. After the warm-up exercise, the researcher helps the patient wear the localized vibration instrument. During the vibration, participants will hold onto the handle to ensure balance stability.

Study summary

Pulmonary rehabilitation is effective in improving exercise tolerance, dyspnea, and fatigue in patients with COPD, and exercise training is an important component of pulmonary rehabilitation. Vibration training can be used as a supplement or alternative to traditional exercise and is a short, safe rehabilitation training.

COPD patients will be recruited and randomly assigned to the control group, whole-body vibration training group, or local vibration training group. The study aims to confirm the rehabilitative benefits of enhancing lower limb muscle strength, exercise endurance, and the quality of life related to COPD in patients.

Eligibility

Sex
ALL
Min age
40 Years
Max age
99 Years
Healthy volunteers
No
Inclusion Criteria: 1. Age ≥ 40. 2. Diagnosis of chronic obstructive pulmonary disease (COPD) based on the criteria established by the Global Initiative for Chronic Obstructive Lung Disease (GOLD). 3. Disease Severity: FEV1 \< 50% or COPD patients who have used systemic corticosteroids due to an acute exacerbation of COPD within the past year and are currently in a stable condition. 4. Willingness to participate in vibration exercise intervention and ability to comply with the study activities, including signing the informed consent form. 5. Clear consciousness, normal cognitive function, and ability to communicate in Mandarin or Taiwanese for understanding experimental procedures and relevant instructions. Exclusion Criteria: 1. Engages in regular physical activity, exercising at least 3 times a week for over 30 minutes, with a Borg Scale rating of 3 for breathlessness after exercise. 2. The interval since the last pulmonary rehabilitation is less than three months. 3. Contraindications to vibration therapy: pregnancy, cardiovascular diseases (with a pacemaker or stent), intervertebral disc diseases, tendinitis, arthritis, hernia, presence of tumors, orthopedic or trauma-related conditions, epilepsy, history of deep vein thrombosis, patients with internal implants. 4. Inability to undergo training or walk due to physical factors, such as being bedridden for an extended period, relying on a ventilator for an extended period, prone to dizziness, central nervous system disorders, etc. 5. Underwent lower limb-related surgery within the past year or is in the recovery period post-surgery. 6. Currently diagnosed with cancer or undergoing cancer treatment. 7. Participation in other research studies.

Primary outcome measure(s)

  • 6 Minute Walking Test — Base line, Week12, Week16
    This test measures how far the patient can walk in 6 minutes, with a greater distance indicating better performance.
  • Maximal voluntary contraction force — Base line, Week12, Week16
    The readings from the digital dynamometer can be converted into kilograms, with higher values indicating greater muscle strength.

Trial sites (1)

FacilityCityRegionStatus
Taipei Medical University WanFang Hospital Taipei Wenshan Dist Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06413524 on ClinicalTrials.gov ↗ ← All trials in Taiwan